urea has been researched along with Glomerulonephritis, Membranous in 6 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We compare the change in serum Cystain C (CysC), urea, creatinine (CREA), uric acid (UA), total protein (TP), albumin (ALB), IgG4 and 24-h urinary protein (proteinuria, PRO) between PLA2RAb+ and PLA2RAb- of IMN patients." | 3.81 | Comparison of biomarkers between PLA2RAb+ and PLA2RAb- in patients with idiopathic membranous nephropathy. ( Jiang, Y; shuai, L; Wang, W; Xun, C, 2015) |
| " Rosiglitazone limited the development of proteinuria and prevented plasma urea elevation (8." | 3.74 | Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing. ( den Ouden, K; Goldschmeding, R; Joles, JA; Nguyen, TQ; Verhaar, MC; Westerweel, PE, 2008) |
| " The outcome of the disease was on 5 ways: I (17 patients)-long remission without proteinuria or with a presence of non-nephrotic proteinuria, II (11 patients)-relapsing disease, III (22 patients)-persistent nephrotic syndrome with slow progressive renal failure, IV (3 patients) rapid development of chronic renal failure and V (5 cases) remission after long period of occurrence of nephrotic syndrome and elevated serum levels of urea and creatinine." | 3.69 | [Membranous glomerulonephritis]. ( Polenaković, M, 1996) |
| "To find new diagnostic markers for idiopathic membranous nephropathy (IMN) and also conduct preliminary explorations into the possible pathogenesis of IMN by comparing the expression of microRNA-451a (miR-451a), miR-106a, miR-19b, miR-17, and phosphatase and tensin homolog (PTEN) protein in the serum of patients with IMN and healthy controls." | 1.62 | Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy. ( Li, X; Liu, Y; Luo, L; Qin, X; Wu, L; Zhang, X, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 2 |
| Luo, L | 2 |
| Zhou, L | 1 |
| Li, N | 1 |
| Qin, X | 2 |
| Zhang, X | 1 |
| Li, X | 1 |
| Liu, Y | 1 |
| Xun, C | 1 |
| shuai, L | 1 |
| Wang, W | 1 |
| Jiang, Y | 1 |
| Westerweel, PE | 1 |
| den Ouden, K | 1 |
| Nguyen, TQ | 1 |
| Goldschmeding, R | 1 |
| Joles, JA | 1 |
| Verhaar, MC | 1 |
| Cattran, DC | 1 |
| Greenwood, C | 1 |
| Ritchie, S | 1 |
| Bernstein, K | 1 |
| Churchill, DN | 1 |
| Clark, WF | 1 |
| Morrin, PA | 1 |
| Lavoie, S | 1 |
| Polenaković, M | 1 |
1 trial available for urea and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group.
Topics: Adult; Aged; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Hu | 1995 |
5 other studies available for urea and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy.
Topics: Autoantibodies; Biomarkers; Glomerulonephritis, Membranous; Humans; Receptors, Phospholipase A2; Sev | 2022 |
Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy.
Topics: Albumins; Case-Control Studies; Creatinine; Cystatin C; Female; Gene Expression Regulation; Glomerul | 2021 |
Comparison of biomarkers between PLA2RAb+ and PLA2RAb- in patients with idiopathic membranous nephropathy.
Topics: Adult; Antibodies; Biomarkers; Creatinine; Cystatin C; Female; Glomerulonephritis, Membranous; Human | 2015 |
Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing.
Topics: Aneurysm; Animals; Blood Pressure; Bone Marrow Transplantation; Cell Movement; Disease Models, Anima | 2008 |
[Membranous glomerulonephritis].
Topics: Adolescent; Adult; Aged; Creatinine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Huma | 1996 |